Carlos Capela

  • Tropical Negelected Disease
  • Buruli ulcer
  • Host genetics
  • Immunology of infection
  • Chronic ulcers
  • Bacteriophages
  • Autoimmune disease
  • Behçet Disease
  • Systemic lupus erythematosus
  • Antiphospholipid syndrome
  • Polymyositis
  • Autoimmune thyroiditis
  • Rare disease
  • COVID-19

Carlos Alberto Pereira Capela completed his PhD in Medicine in 2017 at the University of Minho – School of Medicine and his Degree in Medicine in 2004 at the University of Porto – Instituto de Ciências Biomédicas Abel Salazar. He is a Medical Specialist; a Hospital Graduated Assistant in Internal Medicine at the Hospital of Braga; the Coordinator of the “Hospital de Dia Médico” at the Hospital of Braga; member of the Pharmacy and Therapeutics Committee at the Hospital of Braga; a member of the Joint Management Committee Hospital of Braga – University of Minho; an Invited Assistant Professor at the University of Minho – School of Medicine; and a Researcher at the Life and Health Sciences Reasearch Institute in the Univeristy of Minho. He has published 28 articles in specialized journals. He has received 4 award and/or honors. He participates as Researcher in 2 projects and is Prinicpal Investigator in 3 project.

Scientific Highlights

1. Identification of host genetic factors associated with suscpetibility/resistance to Buruli Ulcer.

2. Contribution to elucidate time-related lesions evolution in Buruli-ulcer patients;

3. Contribution to understanding the immune response to SARS-CoV-2 infection;


Novel Biomarkers in Fabry disease Progression

Fabry disease (FD) a is multi-systemic, X-linked lysosomal storage disease caused by a range of mutations in the GLA gene that encodes for alpha-galactosidase A (α-gal A). Mutations leading to a deficient or absent activity of the enzyme α-gal A result in a progressive accumulation…

Read More